Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92 SAR | -2.13% | -3.26% | -13.04% |
30/04 | Aldawaa Medical Services Posts Higher Q1 Net Profit, Revenue | MT |
30/04 | Al-Dawaa Medical Services Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.04% | 2.13B | - | ||
-34.16% | 14.83B | B- | ||
-23.79% | 12.04B | B | ||
-25.47% | 6.52B | B | ||
+14.96% | 6.44B | C | ||
-9.49% | 6.15B | C+ | ||
-2.48% | 4.64B | D- | ||
+60.00% | 4.62B | C | ||
-8.10% | 3.93B | B | ||
-11.16% | 3.49B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4163 Stock
- Ratings Al-Dawaa Medical Services Company